Sun Pharma to acquire US-based Organon in $11.75 billion deal, among biggest overseas buys by Indian firm - The Times of India
Sun Pharma to acquire US-based Organon in $11.75 billion deal, among biggest overseas buys by Indian firm The Times of India
ORIGINAL SOURCE →via M&A News (GN)
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · IN
- [CONFLICT] Sun Pharma to buy Organon for $11.75B in major portfolio expansion
- [FINANCE] The cost of bringing down inflation in India, U.S. and U.K. | Data
- [CONFLICT] Gold price prediction today: Will gold prices continue to be volatile? Key levels to watch out for April - The Times of India
- [ENERGY] Record solar, wind surge drives 3.3% drop in India’s fossil generation in 2025
- [CONFLICT] Run a marathon? Try 100 in 100 days
- [CONFLICT] 'Same feeling in India': Congress leader's take on Trump shooting attempt sparks row; BJP says ‘Is it even surprising?’